These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1074 related items for PubMed ID: 17320241

  • 1. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL, Stammer H, Jost G, Rufli T, Büchner S, Bigliardi-Qi M.
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases.
    Metze D, Reimann S, Beissert S, Luger T.
    J Am Acad Dermatol; 1999 Oct; 41(4):533-9. PubMed ID: 10495371
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endogenous opioids, mu-opiate receptors and chloroquine-induced pruritus: a double-blind comparison of naltrexone and promethazine in patients with malaria fever who have an established history of generalized chloroquine-induced itching.
    Ajayi AA, Kolawole BA, Udoh SJ.
    Int J Dermatol; 2004 Dec; 43(12):972-7. PubMed ID: 15569037
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R, Matthews S, Arshad SH, McDonald S, Robinson J, Schapira C, Foote KD, Baird-Snell M, Gregory T, Pollock I, Stevens MT, Edwards AM.
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [Abstract] [Full Text] [Related]

  • 8. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
    Phan NQ, Bernhard JD, Luger TA, Ständer S.
    J Am Acad Dermatol; 2010 Oct; 63(4):680-8. PubMed ID: 20462660
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania.
    Grant JE, Kim SW, Odlaug BL.
    Biol Psychiatry; 2009 Apr 01; 65(7):600-6. PubMed ID: 19217077
    [Abstract] [Full Text] [Related]

  • 13. Antipruritic effect of oral cyclosporin A in atopic dermatitis.
    Wahlgren CF, Scheynius A, Hägermark O.
    Acta Derm Venereol; 1990 Apr 01; 70(4):323-9. PubMed ID: 1977258
    [Abstract] [Full Text] [Related]

  • 14. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF, Calvieri S, Ortonne JP, Ho VC, Weise-Riccardi S, Barbier N, Paul CF.
    Br J Dermatol; 2007 Nov 01; 157(5):954-9. PubMed ID: 17935515
    [Abstract] [Full Text] [Related]

  • 15. Naltrexone for the management of post-burn pruritus: A preliminary report.
    LaSalle L, Rachelska G, Nedelec B.
    Burns; 2008 Sep 01; 34(6):797-802. PubMed ID: 18325676
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of topically applied aspirin on localized circumscribed neurodermatitis.
    Yosipovitch G, Sugeng MW, Chan YH, Goon A, Ngim S, Goh CL.
    J Am Acad Dermatol; 2001 Dec 01; 45(6):910-3. PubMed ID: 11712038
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream.
    Chunharas A, Wisuthsarewong W, Wananukul S, Viravan S.
    J Med Assoc Thai; 2002 Apr 01; 85(4):482-7. PubMed ID: 12118496
    [Abstract] [Full Text] [Related]

  • 19. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH, Lee KH, Jautova J, Wohlrab J, Guettner A, Mizutani G, Hultsch T.
    Br J Dermatol; 2009 Feb 01; 160(2):415-22. PubMed ID: 19067708
    [Abstract] [Full Text] [Related]

  • 20. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC, Greif C, Metzner U, Wigger-Alberti W, Elsner P.
    Skin Pharmacol Physiol; 2007 Feb 01; 20(3):133-40. PubMed ID: 17191036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.